NJ Drug Co. Pleads Guilty To Gel Contamination Charges

Law360, New York (July 7, 2016, 1:31 PM EDT) -- Pharmaceutical Innovations Inc. on Wednesday admitted to distributing ultrasound gel contaminated with infectious bacteria in 2012, ending both civil and criminal suits in New Jersey federal court brought by the U.S. Department of Justice.

The Newark-based manufacturer will be on probation for two years and must pay $100,000 in fines and forfeitures after pleading guilty to two misdemeanor counts of introducing adulterated medical devices into interstate commerce. As part of the civil settlement, Pharmaceutical Innovations agreed to pay for regular audits by outside parties and the destruction of the contaminated gel which had been seized by the federal government in 2012....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!